<DOC>
	<DOCNO>NCT02897726</DOCNO>
	<brief_summary>The purpose study evaluate compare safety pharmacokinetics NVP-1402 NVP-1402R healthy male subject .</brief_summary>
	<brief_title>A Study Evaluate Safety Pharmacokinetics NVP-1402</brief_title>
	<detailed_description>This study design randomize , open-label , active-controlled crossover assignment evaluate compare safety pharmacokinetics NVP-1402 NVP-1402R healthy male subject . The safety assess adverse event 17 day administration . Additional variable ( ECGs , laboratory test , vital sign , ) also record assess .</detailed_description>
	<criteria>Healthy males No history clinically significant medical disorder Capable consent participate study History hypersensitive reaction study drug relate drug Any significant abnormality find screen Any significant medical history History alcohol abuse , smoke continuously History drug abuse Clinically significant surgery within 4 week prior administration study drug Participation another clinical trial within 3 month prior administration study drug</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>